603108 润达医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,510,506-9.11%6,998,5308,311,7809,147,37310,494,419
减:营业总成本1,504,546-11.26%7,099,4747,994,7838,651,9939,643,284
    其中:营业成本1,159,432-11.93%5,501,6286,203,4926,718,3717,557,067
               财务费用62,665-1.93%273,516313,435316,682323,591
               资产减值损失(267)279.94%(208,737)(36,170)(34,500)(40,772)
公允价值变动收益------------
投资收益12,479-39.64%20,795109,821231,999137,048
    其中:对联营企业和合营企业的投资收益12,969-37.25%18,978108,488139,609138,057
营业利润(35,366)-27.98%(450,256)354,060646,803816,373
利润总额(36,032)-26.05%(460,637)345,542655,555819,651
减:所得税费用9,942-48.05%57,514156,084212,920164,541
净利润(45,974)-32.25%(518,151)189,458442,636655,110
减:非控股权益7,587443.61%30,243134,177169,339237,364
股东净利润(53,561)-22.67%(548,394)55,281273,296417,746

市场价值指针
每股收益 (元) *-0.090-18.18%-0.9100.0900.4700.720
每股派息 (元) *------0.0300.1000.150
每股净资产 (元) *6.091-13.26%6.1947.1367.0606.519
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容